Hide filtersShow filters × Close Bryan, Garnier & Co acts as Sole Financial Advisor, Sole Global Coordinator and Sole Bookrunner to McPhy on a EUR 180m Follow-on Offering including Strategic Investments from Chart Industries and Technip Energies Bryan, Garnier & Co acts as Sole Financial Advisor to INNOTHERA Group on its acquisition of Gibaud Bryan, Garnier & Co acts as Sole Financial Advisor to Sword Group SE on the disposal of its French unit, Sword France, to Argos Wityu Bryan, Garnier & Co acts as Sole Financial Advisor to EasyVista (Euronext: ALEZV) on a contemplated take-private led by Eurazeo PME Bryan, Garnier & Co acts as Joint Bookrunner on Sensorion’s EUR 31 million Follow-on Offering with top tier US and European biotech specialists and institutional investors Bryan, Garnier & Co acts as European Lead Manager to Humanigen on its USD 78 million Follow-on Offering Bryan, Garnier & Co acts as Joint Bookrunner to Azelio on its SEK 270 million Follow-on Offering Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Innovasjon on the sale of the company to Visolit Bryan, Garnier & Co acts as Co-manager to BioNTech on its USD511.5 million upsized Publicly-marketed Follow-on Offering Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to Carbios on its EUR 37 million upsized Follow-on Offering Bryan, Garnier & Co advises Prosoft on its combination with personnel service software provider Landwehr, which is backed by growth technology investor Lea Partners Bryan, Garnier & Co acts as Sole Global Coordinator on a EUR 7.3 million Rights Issue for medtech company Pixium Vision
